Randomized, Double Blinded, Placebo Controlled Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption
Phase of Trial: Phase II
Latest Information Update: 14 Dec 2017
At a glance
- Drugs Colesevelam (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 07 Dec 2017 Status changed from not yet recruiting to recruiting.
- 09 Oct 2017 Planned initiation date changed from 4 Sep 2017 to 1 Nov 2017.
- 04 Sep 2017 New trial record